Stock Analysis on Net

Medtronic PLC (NYSE:MDT)

Enterprise Value to EBITDA (EV/EBITDA)

Microsoft Excel

Earnings before Interest, Tax, Depreciation and Amortization (EBITDA)

Medtronic PLC, EBITDA calculation

US$ in millions

Microsoft Excel
12 months ended: Apr 28, 2023 Apr 29, 2022 Apr 30, 2021 Apr 24, 2020 Apr 26, 2019 Apr 27, 2018
Net income attributable to Medtronic 3,758 5,039 3,606 4,789 4,631 3,104
Add: Net income attributable to noncontrolling interest 26 23 24 17 19 (9)
Add: Income tax expense 1,580 455 265 (751) 547 2,580
Earnings before tax (EBT) 5,364 5,517 3,895 4,055 5,197 5,675
Add: Interest expense, net 636 553 925 1,092 1,444 1,146
Earnings before interest and tax (EBIT) 6,000 6,070 4,820 5,147 6,641 6,821
Add: Depreciation and amortization 2,697 2,707 2,702 2,663 2,659 2,644
Earnings before interest, tax, depreciation and amortization (EBITDA) 8,697 8,777 7,522 7,810 9,300 9,465

Based on: 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26), 10-K (reporting date: 2018-04-27).

Item Description The company
EBITDA To calculate EBITDA analysts start with net earnings. To that earnings number, interest, taxes, depreciation, and amortization are added. EBITDA as a pre-interest number is a flow to all providers of capital. Medtronic PLC EBITDA increased from 2021 to 2022 but then slightly decreased from 2022 to 2023.

Enterprise Value to EBITDA Ratio, Current

Medtronic PLC, current EV/EBITDA calculation, comparison to benchmarks

Microsoft Excel
Selected Financial Data (US$ in millions)
Enterprise value (EV) 123,317
Earnings before interest, tax, depreciation and amortization (EBITDA) 8,697
Valuation Ratio
EV/EBITDA 14.18
Benchmarks
EV/EBITDA, Competitors1
Abbott Laboratories 18.31
Cigna Group 12.58
CVS Health Corp. 7.45
Elevance Health Inc. 10.76
Humana Inc. 6.10
Intuitive Surgical Inc. 53.72
Shockwave Medical Inc. 62.86
UnitedHealth Group Inc. 13.32
EV/EBITDA, Sector
Health Care Equipment & Services 13.23
EV/EBITDA, Industry
Health Care 18.29

Based on: 10-K (reporting date: 2023-04-28).

1 Click competitor name to see calculations.

If the company EV/EBITDA is lower then the EV/EBITDA of benchmark then company is relatively undervalued.
Otherwise, if the company EV/EBITDA is higher then the EV/EBITDA of benchmark then company is relatively overvalued.


Enterprise Value to EBITDA Ratio, Historical

Medtronic PLC, historical EV/EBITDA calculation, comparison to benchmarks

Microsoft Excel
Apr 28, 2023 Apr 29, 2022 Apr 30, 2021 Apr 24, 2020 Apr 26, 2019 Apr 27, 2018
Selected Financial Data (US$ in millions)
Enterprise value (EV)1 132,878 131,529 183,640 139,945 148,881 131,974
Earnings before interest, tax, depreciation and amortization (EBITDA)2 8,697 8,777 7,522 7,810 9,300 9,465
Valuation Ratio
EV/EBITDA3 15.28 14.99 24.41 17.92 16.01 13.94
Benchmarks
EV/EBITDA, Competitors4
Abbott Laboratories 19.49 15.85 17.42 25.99 21.70
Cigna Group 12.11 8.88 9.06 6.31 8.42
CVS Health Corp. 8.03 12.42 10.41 8.56 9.43
Elevance Health Inc. 10.24 10.26 10.05 7.57 9.05
Humana Inc. 7.33 11.59 11.22 6.91 9.30
Intuitive Surgical Inc. 53.82 41.52 44.54 59.12 37.53
Shockwave Medical Inc. 49.39 52.02
UnitedHealth Group Inc. 13.60 15.11 17.39 13.39 13.82
EV/EBITDA, Sector
Health Care Equipment & Services 13.58 13.91 15.27 12.79 12.97
EV/EBITDA, Industry
Health Care 18.80 13.80 13.98 16.48 14.28

Based on: 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26), 10-K (reporting date: 2018-04-27).

1 See details »

2 See details »

3 2023 Calculation
EV/EBITDA = EV ÷ EBITDA
= 132,878 ÷ 8,697 = 15.28

4 Click competitor name to see calculations.

Valuation ratio Description The company
EV/EBITDA Enterprise value to earnings before interest, tax, depreciation and amortization is a valuation indicator for the overall company rather than common stock. Medtronic PLC EV/EBITDA ratio decreased from 2021 to 2022 but then slightly increased from 2022 to 2023.